Explore / Peer-reviewed article
Peer-reviewed article

Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.

Fricke JiD, Sherwood AMiD, Halberstadt ALiD, Kargbo RB, Hoffmeister DiD

Journal of natural productsMar 5, 2021Germany, United States12 citationsDOI: 10.1021/acs.jnatprod.1c00087

Abstract

A novel analogue of psilocybin was produced by hybrid chemoenzymatic synthesis in sufficient quantity to enable bioassay. Utilizing purified 4-hydroxytryptamine kinase from <i>Psilocybe cubensis</i>, chemically synthesized 5-methylpsilocin (<b>2</b>) was enzymatically phosphorylated to provide 5-methylpsilocybin (<b>1</b>). The zwitterionic product was isolated from the enzymatic step with high purity utilizing a solvent-antisolvent precipitation approach. Subsequently, <b>1</b> was tested for psychedelic-like activity using the mouse head-twitch response assay, which indicated activity that was more potent than the psychedelic dimethyltryptamine, but less potent than that of psilocybin.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDMT

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.